US9526728B2 - Medical use of a DPP-4 inhibitor - Google Patents

Medical use of a DPP-4 inhibitor Download PDF

Info

Publication number
US9526728B2
US9526728B2 US14/633,489 US201514633489A US9526728B2 US 9526728 B2 US9526728 B2 US 9526728B2 US 201514633489 A US201514633489 A US 201514633489A US 9526728 B2 US9526728 B2 US 9526728B2
Authority
US
United States
Prior art keywords
mg
yl
dpp
patient
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US14/633,489
Other versions
US20150246045A1 (en
Inventor
Thomas Klein
Andrew Advani
Kim Alexander Connelly
Richard Ernest Gilbert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP14157222.2 priority Critical
Priority to EP14157222 priority
Priority to EP14157222 priority
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Assigned to BOEHRINGER INGELHEIM INTERNATIONAL GMBH reassignment BOEHRINGER INGELHEIM INTERNATIONAL GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CONNELLY, Kim Alexander, GILBERT, RICHARD ERNEST, ADVANI, Andrew, KLEIN, THOMAS
Publication of US20150246045A1 publication Critical patent/US20150246045A1/en
Publication of US9526728B2 publication Critical patent/US9526728B2/en
Application granted granted Critical
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links